Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis

27 August 2023 (16:15 - 17:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Julius Heemelaar

Alrijne Hospital Leiderdorp, Leiderdorp (Netherlands (The))

7 More presentations in this session

Presentation thumbnail

Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy

Associate Professor F. Guerra (Ancona, IT)

Abstract Slides Video

Presentation thumbnail

Arterial inflammation induced by immune checkpoint inhibitors assessed on 18F-FDG PET-CT scans in stage III/IV melanoma patients

Miss E. Polomski (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study

Doctor S. Tan (Melbourne, AU)

Abstract Slides Video

Presentation thumbnail

Gender differences in cardio-oncology care of patients treated with immune checkpoint inhibitor therapy

Associate Professor R. Mincu (Essen, DE)

Abstract Slides Video

Presentation thumbnail

Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels and reduces myocardial strain through NLRP3 and MyD-88 pathways

Doctor N. Maurea (Naples, IT)

Abstract Slides Video

Access the full session

Session thumbnail

T-cells, checkpoint inhibitors, and cardiac complications

The Event

Event poster

ESC Congress 2023

27 August 2023 16:15 CET

You may be interested in

Congress Presentation

Case 2: cardiac arrhythmias during immune checkpoint inhibitors therapy

Congress Presentation

Cardiovascular adverse events in primary lung cancer patients treated with immune checkpoint inhibitors: a nationwide database study

Congress Presentation

Immune checkpoint inhibitor associated myocarditis - lessons from a case series

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources